Exon skipping mutations in neurofibromatosis
Exon skipping mutations in neurofibromatosis
Defects at the level of pre-mRNA splicing represent a common source of disease mutations in almost all known diseases with a genetic aetiology. In general, it is commonly accepted that 15% of all pathogenic mutations are caused by splicing defects. However, this is probably a conservative estimate since clinical practice has only recently begun to routinely assess for this types of abnormalities. Therefore, it is expected that many currently unclassified or apparently harmless genetic variants will really turn out to be splicing-affecting defects. It is also well known that some genes are more susceptible than others to alterations in their splicing processes. Among these genes, one of the most representative is the NF-1 gene. In this gene, almost 50% of all reported disease-causing mutations can be directly attributed to alterations of the pre-mRNA process. In this chapter, we review the splicing process of the NF-1 gene and the most commonly used methods to identify splicing alterations. In particular, we provide practical notes on how to perform this analysis to maximize the chance of correctly identifying aberrant pre-mRNA splicing events in this gene.
NF-1 gene, neurofibromatosis, neurofibromin, pre-mRNA splicing, minigene systems, exon skipping
65-76
Buratti, Emanuele
57e8e002-a8c2-409a-ac29-2fc4a1d1c8b9
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
30 April 2012
Buratti, Emanuele
57e8e002-a8c2-409a-ac29-2fc4a1d1c8b9
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Abstract
Defects at the level of pre-mRNA splicing represent a common source of disease mutations in almost all known diseases with a genetic aetiology. In general, it is commonly accepted that 15% of all pathogenic mutations are caused by splicing defects. However, this is probably a conservative estimate since clinical practice has only recently begun to routinely assess for this types of abnormalities. Therefore, it is expected that many currently unclassified or apparently harmless genetic variants will really turn out to be splicing-affecting defects. It is also well known that some genes are more susceptible than others to alterations in their splicing processes. Among these genes, one of the most representative is the NF-1 gene. In this gene, almost 50% of all reported disease-causing mutations can be directly attributed to alterations of the pre-mRNA process. In this chapter, we review the splicing process of the NF-1 gene and the most commonly used methods to identify splicing alterations. In particular, we provide practical notes on how to perform this analysis to maximize the chance of correctly identifying aberrant pre-mRNA splicing events in this gene.
This record has no associated files available for download.
More information
Published date: 30 April 2012
Keywords:
NF-1 gene, neurofibromatosis, neurofibromin, pre-mRNA splicing, minigene systems, exon skipping
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 337217
URI: http://eprints.soton.ac.uk/id/eprint/337217
PURE UUID: aa114f96-c944-4d4b-99e4-ee5a2dba77ce
Catalogue record
Date deposited: 20 Apr 2012 09:00
Last modified: 15 Mar 2024 03:30
Export record
Altmetrics
Contributors
Author:
Emanuele Buratti
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics